Skip to content

Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study

Randomized Study Comparing the Effects of Gastric Bypass Using a Long BP-limb vs. a Long Alimentary Limb in Morbid Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01514799
Enrollment
140
Registered
2012-01-23
Start date
2011-08-29
Completion date
2020-02-01
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity, Weight Loss

Keywords

gastric bypass, morbid obesity, gut function, weight loss

Brief summary

Super Obesity, i.e. a BMI above 50, is difficult to treat. Normal gastric bypass surgery is not always enough for proper weight control. Bypassing a longer segment of the gut may be more beneficial. Which part to bypass is not clear. The investigators want to compare the effects between preventing a 60 cm proximal (oral) portion of the jejunum from food contact with the effects when preventing a 200 cm part of the jejunum from contact with bile and pancreatic juice. Endpoints are quality of life, gastrointestinal function, and weight development.

Detailed description

Two variations of gastric bypass are compared: Method 1 (test method):A 200 cm BP-limb (distance Treitz to EA) + 150 cm common channel (EA to ileocecal valve) + Roux-Y-limb variable Method 2 (standard method): A 60 cm BP limb + 150 cm Roux-Y-limb + common channel variable. Patients are evaluated according to the principles of the Scandinavian Obesity surgery registry (SOReg) with the addition of two additional questionnaires. FU time is set at 5 years.

Interventions

PROCEDUREgastric bypass

two techniques of gastric bypass for studying the effects of making a long BP-limb

Sponsors

Aleris Obesity
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Randomisation in the OR, (closed envelopes, blocks of six) no further info to ward or follow-up unit. No specific info as to randomisation outcome given to patients, all patients follow same protocol. Code number in operative charts.

Intervention model description

Randomised study between long and standard biliopancreatic limb in gstric bypass surgery

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* BMI 50-65 * Age 18-55 * Conservative attempts at weight reduction failed

Exclusion criteria

* Inability to speak and understand the Swedish language * Residence outside the county of Skåne * Psychotic disease * Inflammatory bowel disease

Design outcomes

Primary

MeasureTime frameDescription
body weight reduction5 yearsabsolute BW reduction, percentage of patients reaching BMI below 30,

Secondary

MeasureTime frameDescription
gastrointestinal function5 yearsSF-36, Op-9, GSRS and TFEQ are used in patient assessed variables

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026